Arrowstreet Capital
AEHR icon

Arrowstreet Capital’s Aehr Test Systems AEHR Stock Holding History

Arrowstreet Capital’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46M Buy
+35,987
New +$3.29M ﹤0.01% 1400
2022
Q2 		– Sell
-45,602
Closed -$463K – 1206
2022
Q1 		$463K Sell
45,602
-292,521
-87% -$3.74M ﹤0.01% 1040
2021
Q4 		$8.18M Buy
+338,123
New +$6.61M 0.01% 701

Other funds holding AEHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital's AEHR Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Aehr Test Systems (AEHR) in Q2 2026: 35,987 shares worth $3.46M. The stake represents ﹤0.01% of the portfolio and ranks #1400 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in AEHR as recently as Q1 2022.

Arrowstreet Capital first reported a position in AEHR in Q4 2021 and has held it in 3 quarters since. The position peaked at $8.18M in Q4 2021. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Arrowstreet Capital held 35,987 shares of Aehr Test Systems worth $3.46M as of Q2 2026.
  • Aehr Test Systems was a new Arrowstreet Capital position in Q2 2026.
  • Aehr Test Systems made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1400 holding.
  • Arrowstreet Capital first reported a position in Aehr Test Systems in Q4 2021 and has held it in 3 quarters since.
  • Arrowstreet Capital's Aehr Test Systems position peaked at $8.18M in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.